Shanghai Rightongene Biotechnology Co Ltd Class A 688217
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 25.85
- Day Range
- CNY 25.26–26.35
- 52-Week Range
- CNY 19.34–43.79
- Bid/Ask
- CNY 0.00 / CNY 0.00
- Market Cap
- CNY 1.46 Bil
- Volume/Avg
- 222,730 / 448,767
Key Statistics
- Price/Earnings (Normalized)
- 71.89
- Price/Sales
- 5.24
- Dividend Yield (Trailing)
- 0.69%
- Dividend Yield (Forward)
- 0.69%
- Total Yield
- 0.70%
Company Profile
Shanghai Rightongene Biotechnology Co Ltd is engaged in the research and development, production, sales, scientific research and testing services of in vitro diagnostic products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 501
- Website
- http://www.rightongene.com
Comparables
Valuation
|
Metric
|
688217
|
688253
|
000710
|
|---|---|---|---|
Price/Earnings (Normalized) | 71.89 | 23.42 | — |
Price/Book Value | 1.55 | 2.80 | 1.70 |
Price/Sales | 5.24 | 8.92 | 2.90 |
Price/Cash Flow | 69.58 | 13.52 | 30.36 |
Price/Earnings
688217
688253
000710
Financial Strength
|
Metric
|
688217
|
688253
|
000710
|
|---|---|---|---|
Quick Ratio | 9.93 | 10.60 | 1.63 |
Current Ratio | 11.97 | 11.04 | 2.02 |
Interest Coverage | −14.95 | 1,693.02 | — |
Quick Ratio
688217
688253
000710
Profitability
|
Metric
|
688217
|
688253
|
000710
|
|---|---|---|---|
Return on Assets (Normalized) | 0.35% | 4.47% | −13.01% |
Return on Equity (Normalized) | 0.39% | 4.81% | −18.59% |
Return on Invested Capital (Normalized) | 0.15% | 4.51% | −15.87% |
Return on Assets
688217
688253
000710
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Nphqygprq | Pzbz | $586.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Nwrbdgm | Tvcdjqh | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Cwvggrsf | Qwxphc | $108.2 Bil | |
MRNA
| Moderna Inc | Ktthzsyw | Zqfm | $50.9 Bil | |
ARGX
| argenx SE ADR | Scqzzskp | Fcz | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Dbmlrsz | Csj | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Xjjdznxqs | Phhrsvs | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Rvjmsktwh | Qwnfwmp | $14.6 Bil | |
INCY
| Incyte Corp | Pvfztlck | Flfkp | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Vnrjtqrtqq | Bnrpp | $12.3 Bil |